The proposed Modification No. M0010 to Contract No. CW94739 with Ramsell Corporation aims to increase the not-to-exceed (NTE) amount of the contract by $3,000,000, raising the total ceiling to $13,500,000. This modification is essential for Ramsell to continue delivering a Pharmacy Benefit Management System (PBMS) for various health programs under DC Health, including the Aids Drug Assistance Program and the Medication Assisted Therapy program. The increase is necessary due to unforeseen costs, particularly a projected rise in drug expenditures driven by higher client usage and escalating drug prices. The contract is set to run from January 18, 2025, to January 17, 2026, and has been certified for funding availability consistent with the financial plan and budget.

The modification also includes a revised price schedule detailing the specific costs associated with the services provided under the contract, which encompasses fixed prices and cost reimbursements. The total not-to-exceed amount for both option periods is established at $13,500,000, contributing to an overall grand total for all years of the contract projected at $52,545,795. Importantly, all other terms and conditions of the original contract remain unchanged and in full effect, ensuring continued access to essential prescription coverage and healthcare for District residents infected with HIV who are uninsured or underinsured.